Upon conclusion of this
meeting, participants will have increased ability to:
1. Recognize patients who are at high risk of developing CAD, atrial fibrillation or heart failure and how to approach diagnostic and therapeutic challenges.
2. Understand recently presented and published clinical trial results and how they can impact on clinical practice and management of patients with acute coronary syndromes, heart failure, and stable coronary artery disease.
3. Differentiate the mechanism of action in the management of disorders such as hypertension, dyslipidemia, diabetes, heart failure and arrhythmia through review of available agents.
4. Recognize the risks and benefits of various therapeutic options in managing patients with CAD.
5. Develop the most appropriate management strategy for patients with atrial fibrillation.
6. Appropriately implement results from recent trials of antiplatelet agents into clinical practice.
7. Recognize patients who are at high risk of developing CAD and match their risk to appropriate risk reducing strategies, including cholesterol reduction, glycemic control and BP control.
|
|
|
Saturday, April 9, 2011 | Four Seasons Hotel
AGENDA
730 |
Registration and Continental Breakfast |
|
| 8:30 |
Welcome and Introduction |
Howard Leong-Poi, MD |
| |
|
|
I High Risk Management in Your Office
Chair: John Graham, MD |
| |
|
|
| 8:40 |
Diabetes is a cardiovascular disease: Who needs a Diabetologist?
|
Michael Farkouh, MD |
| 9:00 |
Heart Failure 2011: Let the good times roll |
Abdul Al-Hesayen, MD |
| 9:20 |
I can't get the blood pressure to target! Approaches to the patient with resistant hypertension
|
Phil McFarlane, MD |
| 9:40 |
Case Presentation / Panel Discussion |
|
| |
|
|
| 10:10–10:40 |
NUTRITION BREAK |
|
| II Clinical Trials In The Past Year That Impact On My Practice |
| |
|
|
| 10:40 |
An Update on Important Studies |
Shaun Goodman, MD |
| |
|
|
III Improving Outcomes in AF: New CCS Guidelines
Chair: Howard Leong-Poi, MD |
| |
|
|
| 11:00 |
Where’s Waldo? Detection of Atrial Fibrillation |
Arnold Pinter, MD |
| 11:20 |
I’ve got rhythm – who could ask for anything more? |
Iqwal Mangat, MD |
| 11:40 |
Stroke prevention: Have we found the Holy Grail? |
Victoria Korley, MD |
| 12:00 |
Case Presentation / Panel Discussion |
|
| |
|
|
| 12:30 –13:30 |
LUNCH |
|
IV Important Issues in my CV patients
Chair: Neil Fam, MD |
| |
|
|
| 13:30 |
Clopidogrel, Prasugrel and Ticagrelor for ACS: The Paradox of Choice |
Asim Cheema, MD |
| 13:50 |
My office patient is having chest pain: now what? |
Michael Freeman, MD |
| 14:10 |
Novel Medical Therapies for patients living with chronic CAD: Who needs a Cath Lab or a surgeon if you have good drugs? |
Beth Abramson, MD |
| 14:30 |
Case Presentation / Panel Discussion / Q & A with Audience Response System |
|
| |
|
|
| 15:00 |
CONCLUSION |
|

|
This program meets the accreditation criteria of The College of Family Physicians of Canada and has been accredited for up to 5.0 Mainpro-M1 credits.
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada, approved by the University of Toronto (5.0 credits) |
|
|